Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 21 Carcinoma, Non-Small-Cell Lung 21 Breast Neoplasms 20 Neoplasms 19 Stomach Neoplasms 15 Colorectal Neoplasms 15 Lung Neoplasms 13 Endometrial Neoplasms 13 Pancreatic Neoplasms 11 Leukemia, Myeloid, Acute 10 Colonic Neoplasms 9 Carcinoma, Hepatocellular 9 Oropharyngeal Neoplasms 6 Neoplasm Metastasis 6 Multiple Myeloma 6 Melanoma 6 Lymphoma, Large B-Cell, Diffuse 6 Esophageal Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Sarcoma 5 Rectal Neoplasms 5 Mouth Neoplasms 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Head and Neck Neoplasms 5 Uterine Cervical Neoplasms 4 Recurrence 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Mantle-Cell 4 Leukemia, Myelomonocytic, Acute 4 Leukemia, Monocytic, Acute 4

Interventions

Cisplatin 12 Everolimus 10 Nivolumab 8 Etoposide 8 Temozolomide 6 Carboplatin 6 atezolizumab 5 Irinotecan 5 Ipilimumab 5 Fluorouracil 5 Bevacizumab 5 pembrolizumab 4 lutetium Lu 177 dotatate 4 Capecitabine 4 avelumab 3 Paclitaxel 3 IFL protocol 3 surufatinib 2 sintilimab 2 gallium Ga 68 dotatate 2 dostarlimab 2 cabozantinib 2 belinostat 2 azaspirane 2 Topotecan 2 Radiosurgery 2 Positron Emission Tomography Computed Tomography 2 PE regimen 2 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2 Magnetic Resonance Imaging 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Neuroendocrine × Observation × Clear all

NCT07192991 2025-09-25

NECTARINE

Latin American Cooperative Oncology Group

Not yet recruiting

Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡